This circular describes the present state of knowledge of the risks of transmission of variant Creutzfeldt-Jakob Disease (vCJD) from one patient to another. It details theaction that health organisations and clinicians should already be taking to reduce the risk of transmission and recommends some further precautionary measures.
It should be read in conjunction with HSC 1999/179 Controls assurance in infection control: Decontamination of medical devices and HSC 1998/123 Governance in the new NHS: Controls assurance statements 1999/2000: Risk management and organisational control.
Contact details for obtaining hard-copy DH publications.

Useful tips to ensure you get the most from PDFs and the free Reader program. Topics covered include accessibility, troubleshooting and searching files.